Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Spironolactone 3mg / Chlorothiazide 30mg capsules
0202040S0AAAMAM
|
Chlorothiazide/spironolactone | Spironolactone with thiazides | Cardiovascular System | No data available |
|
Spironolactone 3mg/5ml oral liquid
0202030S0AADMDM
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 4.5mg/5ml oral liquid
0202030S0AADLDL
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 40mg/5ml oral liquid
0202030S0AADIDI
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 4mg / Chlorothiazide 40mg capsules
0202040S0AAAHAH
|
Chlorothiazide/spironolactone | Spironolactone with thiazides | Cardiovascular System | No data available |
|
Spironolactone 4mg/5ml oral liquid
0202030S0AACWCW
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 5mg / Chlorothiazide 50mg capsules
0202040S0AAAPAP
|
Chlorothiazide/spironolactone | Spironolactone with thiazides | Cardiovascular System | No data available |
|
Spironolactone 5mg/5ml / Chlorothiazide 50mg/5ml liquid
0202040S0AAAKAK
|
Chlorothiazide/spironolactone | Spironolactone with thiazides | Cardiovascular System | No data available |
|
Spironolactone 6.25mg/5ml oral liquid
0202030S0AACTCT
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 6mg / Chlorothiazide 60mg capsules
0202040S0AAARAR
|
Chlorothiazide/spironolactone | Spironolactone with thiazides | Cardiovascular System | No data available |
|
Spironolactone 6mg/5ml oral liquid
0202030S0AADQDQ
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 7.5mg/5ml oral liquid
0202030S0AACVCV
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 75mg/5ml oral liquid
0202030S0AADEDE
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 7mg/5ml oral liquid
0202030S0AACYCY
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 8.3mg/5ml oral liquid
0202030S0AADVDV
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 8mg/5ml oral liquid
0202030S0AADBDB
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spirospare 100 tablets
0202030S0BJACAV
|
Spirospare | Spironolactone | Cardiovascular System | No data available |
|
Staril 10mg tablets
0205051J0BBAAAA
|
Staril | Fosinopril sodium | Cardiovascular System | No data available |
|
Staril 20mg tablets
0205051J0BBABAB
|
Staril | Fosinopril sodium | Cardiovascular System | No data available |
|
Stayveer 62.5mg tablets
0205010U0BCAAAA
|
Stayveer | Bosentan | Cardiovascular System | No data available |
|
Stefluvin XL 80mg tablets
0212000M0BFAAAD
|
Stefluvin | Fluvastatin sodium | Cardiovascular System | No data available |
|
Steriflex No.26 glucose 5%/lidocaine 1g/500ml inf 500ml bags
0203020L0BDAAAE
|
Steriflex (Arrhythmias) | Lidocaine hydrochloride | Cardiovascular System | No data available |
|
Steriflex No.27 glucose 5%/lidocaine 2g/500ml inf 500ml bags
0203020L0BDABAG
|
Steriflex (Arrhythmias) | Lidocaine hydrochloride | Cardiovascular System | No data available |
|
Streptase 1.5million unit inf vials
0210020L0BCACAE
|
Streptase | Streptokinase | Cardiovascular System | No data available |
|
Streptase 250,000unit powder for solution for infusion vials
0210020L0BCADAB
|
Streptase | Streptokinase | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.